Continuous Infusion of Prostacyclin Decreases Plasma Levels of t-PA and PAI-1 in Primary Pulmonary Hypertension

• References

• 1 Rubin LJ. Primary pulmonary hypertension. Chest 1993; 104: 236-250
• 2 Anglés-Cano E, Sultan Y, Clauvel J-P. Predisposing factors to thrombosis in systemic lupus erythematosus. Possible relation to endothelial cell damage J Lab Clin Med 1979; 94: 312-323
• 3 Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70-75
• 4 Higenbottam TW, Spiegelhalter D, Scott J-P, Fuster V, Dinh-Xuan AT, Caine N, Wallwork J. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J 1993; 70: 366-370
• 5 Anglés-Cano E, Grailhe P, Boyer-Neumann C, Brenot F, Peynaud-Debayle E, Azarian R, Simonneau G, Duroux P, Meyer D. Markers of endothelial involvement in chronic pulmonary hypertension. Fibrinolysis 1994; 8 suppl (Suppl. 01) 139 Abstr